Detalhe da pesquisa
1.
Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.
J Neuroinflammation
; 19(1): 148, 2022 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35705992
2.
Prostanoid Receptor Subtypes and Its Endogenous Ligands with Processing Enzymes within Various Types of Inflammatory Joint Diseases.
Mediators Inflamm
; 2020: 4301072, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33273889
3.
Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis.
Mediators Inflamm
; 2017: 9243736, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28316377
4.
Functional and Anatomical Characterization of Corticotropin-Releasing Factor Receptor Subtypes of the Rat Spinal Cord Involved in Somatic Pain Relief.
Mol Neurobiol
; 58(11): 5459-5472, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34331656
5.
Accessibility of axonal G protein coupled mu-opioid receptors requires conceptual changes of axonal membrane targeting for pain modulation.
J Control Release
; 268: 352-363, 2017 Dec 28.
Artigo
Inglês
| MEDLINE | ID: mdl-29054370
6.
Acute mechanical sensitization of peripheral nociceptors by aldosterone through non-genomic activation of membrane bound mineralocorticoid receptors in naive rats.
Neuropharmacology
; 107: 251-261, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27016023
7.
Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes.
Pain
; 157(4): 910-921, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26713421